Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder - PubMed (original) (raw)
Review
Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder
C G Hahn et al. Bipolar Disord. 1999 Dec.
Abstract
Protein kinase C (PKC) is a group of calcium and phospholipid-dependent enzymes, which plays a pivotal role in cell signaling systems. Recently accumulated evidence indicates that alterations in PKC activity play a significant role in the pathophysiology of bipolar disorder. A number of laboratories investigated the effect of mood stabilizers on the regulation of PKC activity in bipolar patients, in animals, and in cultured cells. Following chronic lithium treatment, PKC activation was significantly reduced in rat brains, as measured by the translocation of cytoplasmic PKC to the membrane compartment, or by quantitative binding of the PKC ligand, PDBu. The effect of the therapeutic concentration of lithium in attenuating PKC-dependent intracellular parameters was also demonstrated in cultured cells. More importantly, alterations in platelet PKC was shown in bipolar patients during the manic state of the illness. In comparison to patients with major depressive disorder, schizophrenia, or healthy controls, PKC activity was significantly increased in manic patients, suggesting that changes in PKC may be an illness-specific marker. Interestingly, enhanced PKC activity during mania was suppressed following mood-stabilizer treatment as manic symptoms improved. In parallel to the findings in platelets, postmortem studies demonstrate that membrane-associated PKC and stimulation-induced translocation of cytosolic enzyme to the membrane were also increased in frontal cortex of bipolar patients. Other studies suggest alterations in other signal transduction mechanisms in bipolar disorder. These include alterations in G protein activation, phosphatidylinositol (PI) signaling, cyclic AMP formation, and intracellular calcium homeostasis. The alterations of PKC activity in bipolar disorder may be related to changes in these other intracellular signaling mechanisms. Alternatively, the changes of PKC activity may be the core pathology of the illness. More studies are required to further characterize the association of PKC changes with bipolar disorder, using a proper neuronal model.
Similar articles
- Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.
Hahn CG, Umapathy, Wang HY, Koneru R, Levinson DF, Friedman E. Hahn CG, et al. J Psychiatr Res. 2005 Jul;39(4):355-63. doi: 10.1016/j.jpsychires.2004.10.007. J Psychiatr Res. 2005. PMID: 16044535 Clinical Trial. - [On the relevance of protein kinase C to lithium therapy in bipolar disorder].
Sela B. Sela B. Harefuah. 2004 Jun;143(6):414-6, 462. Harefuah. 2004. PMID: 15524097 Hebrew. - Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients.
Wang HY, Markowitz P, Levinson D, Undie AS, Friedman E. Wang HY, et al. J Psychiatr Res. 1999 Mar-Apr;33(2):171-9. doi: 10.1016/s0022-3956(98)90057-7. J Psychiatr Res. 1999. PMID: 10221749 - [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
Einat H, Chen G, Manji H. Einat H, et al. Harefuah. 2004 Jun;143(6):420-5, 462. Harefuah. 2004. PMID: 15524099 Review. Hebrew.
Cited by
- A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Hong Y, Huang W, Cao D, Xu J, Wei H, Zhang J, Wang L. Hong Y, et al. Psychopharmacology (Berl). 2022 Oct;239(10):3367-3375. doi: 10.1007/s00213-022-06230-5. Epub 2022 Sep 5. Psychopharmacology (Berl). 2022. PMID: 36063207 - Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers.
Lee JG, Woo YS, Park SW, Seog DH, Seo MK, Bahk WM. Lee JG, et al. Clin Psychopharmacol Neurosci. 2022 May 31;20(2):228-239. doi: 10.9758/cpn.2022.20.2.228. Clin Psychopharmacol Neurosci. 2022. PMID: 35466094 Free PMC article. Review. - Trinuclear Calcium Site in the C2 Domain of PKCα/γ Is Prone to Lithium Attack.
Grauffel C, Weng WH, Dudev T, Lim C. Grauffel C, et al. ACS Omega. 2021 Jul 28;6(31):20657-20666. doi: 10.1021/acsomega.1c02882. eCollection 2021 Aug 10. ACS Omega. 2021. PMID: 34396011 Free PMC article. - Putative role of natural products as Protein Kinase C modulator in different disease conditions.
Singh RK, Kumar S, Tomar MS, Verma PK, Kumar A, Kumar S, Kumar N, Singh JP, Acharya A. Singh RK, et al. Daru. 2021 Dec;29(2):397-414. doi: 10.1007/s40199-021-00401-z. Epub 2021 Jul 3. Daru. 2021. PMID: 34216003 Free PMC article. Review. - Chronic lithium treatment alters the excitatory/ inhibitory balance of synaptic networks and reduces mGluR5-PKC signalling in mouse cortical neurons.
Khayachi A, Ase A, Liao C, Kamesh A, Kuhlmann N, Schorova L, Chaumette B, Dion P, Alda M, Séguéla P, Rouleau G, Milnerwood A. Khayachi A, et al. J Psychiatry Neurosci. 2021 Jun 2;46(3):E402-E414. doi: 10.1503/jpn.200185. J Psychiatry Neurosci. 2021. PMID: 34077150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous